Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: Role of the cytoplasmic domain

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2669-2673

  Ritter Jr , G Douglas ^a   Yamshchikov, Galina ^a,d   Cohen, Stuart J ^a   Mulligan, Mark J ^a,b,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 2; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; VIRUS ASSEMBLY; VIRUS PARTICLE;

EID: 0029918147     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2669-2673.1996     Document Type: Article

References (67)

1. Albert, J., U. Bredberg, F. Chiodi, B. Bottiger, E. M. Fenyo, E. Norrby, and G. Biberfeld. 1987. A new human retrovirus isolate of west African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res. Hum. Retroviruses 3:3-10.
2. Arroyo, J., M. Boceta, M. E. Gonzalez, M. Michel, and L. Carrasco. 1995 Membrane permeabilization by different regions of the human immunodeficiency vims type 1 transmembrane glycoprotein gp41. J. Virol. 69:4095-4102.
3. Chakrabarti, L., R. Emerman, P. Tollais, and P. Sonigo. 1989. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J. Virol. 63:4395-4403.
4. Chakrabarti, S., K. Brechung, and B. Moss. 1985 Vaccinia virus expression vector coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
5. Chernomordik, L., A. N. Chanturiya, E. Suss-Toby, E. Nora, and J. Zimmerberg. 1994. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68:7115-7123.
6. DeCock, K. M., G. Adjorlolo, E. Ekpini, T. Sibailly, J. Kouadio, M. Maran, K. Brattegaard, K. M. Vetter, R. Doorly, and H. D. Gayle. 1993. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 270:2083-2086.
7. Delchambre, M., D. Gheysen, D. Thines, C. Thiriart, E. Jacobs, E. Verdin, M. Horth, A. Burny, and F. Bex. 1989. The GAG precursor of simian immunodeficiency virus assembles into virus-like particles EMBO J. 8:2653-2660.
8. Dorfman, T., F. Mammano, W. Haseltine, and H. G. Gottlinger. 1994 Role of the p17 matrix protein in the virion association of the human immunudeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1689-1696
9. Dubay, J. W., S. J. Roberts, B. H. Hahn, and E. Hunter. 1992. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66:6616-6625
10. Eisenberg, D., and M. Wesson. 1990. The most highly amphiphilic a-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41 Biopolymers 29:171-177.
11. Evans, L. A., J. Moreau, K. Odehouri, H. Legg, A. Barboza, D. Cheng-Mayer, and J. A. Levy. 1988. Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. Science 240:1522-1525
12. Freed, E. O., and M. A. Martin. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1984-1989.
13. Gallaher, W. R., J. M. Ball, R. F. Garry, M. C. Griffin, and R. C. Montelaro. 1989. A general model for the transmembrane proteins of HIV and other retroviruses AIDS Res Hum. Retroviruses 5:431-440.
14. SM-related HIV-2 in West Africa. Nature (London) 358:495-499.
15. Gawrisch, K., K. H. Han, J. S. Yang, L. D. Bergelson. and J. A. Ferretti. 1993. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type 1 with lipid bilayers. Biochemistry 32:3112-3118.
16. Gottlinger, H. G., T. Dorfman, E. A. Cohen, and W. A. Haseltine. 1993 Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses Proc. Natl. Acad Sci. USA 90:7381-7385.
17. Gottlinger, H. G., T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci USA 88:3195-3199.
18. Guyader, M., M. Emerman, P. Sonigo, F. Clavel, L. Montagnier, and M. Alizon. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2 Nature (London) 326:662-669
19. Haffar, O., J. Garrigues, B. Travis, P. Moran, J. Zarling, and S.-L. Hu. 1990 Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J. Virol. 64:2653-2659
20. 19a Haffar, O. K., D. J. Dowbenko, and P. W. Berman. 1991. The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes Virology 180:439-441.
21. Haffar, O. K., G. R. Nakamura, and P. W. Berman. 1990. The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines J Virol. 64:3100-3103.
22. Hasegawa, A., H. Tsujimoto, N. Maki, K.-I. Ishikawa, T. Miura, M. Fukasawa, K. Miki, and M. Hayami. 1989. Genomic divergence of HIV-2 from Ghana. AIDS Res Hum. Retroviruses 5:593-604.
23. Hirsch, V. M., P. Edmond son, M. Murphy-Corb, B. Arbeille, P. R. Johnson, and J. L. Mullins. 1989. SIV adaptation to human cells Nature (London) 341:573-574.
24. Hoxie, J. A., L. E. Brass, C. H. Pletcher, B. S. Haggarty, R. Colloran, and B. Hahn. 1991. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4. J. Virol. 65:5096-5101.
25. Johnston, P., J. Dubay, and E. Hunter. 1993. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 67:3077-3086.
26. Jowett, J. B. M., and I. M. Jones. 1993. Glycosylation of the external domain of SIV gp41 is influenced by the cytoplasmic tail. AIDS Res. Hum. Retroviruses 9:197-198.
27. Kanki, P. J., K. U. Travers, S. Mboup, C.-C. Hsieh, R. G. Marlink, A. Gueye-Ndiaye, T. Siby, I. Thior, M. Hernandez-Avila, J.-L. Sankale, I. NDoye, and M. E. Essex. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946.
28. Kawai, S., and H. Hanafusa. 1973. Isolation of defective mutant of avian sarcoma virus Proc. Natl. Acad. Sci. USA 70:3493-3497.
29. Klimkait, T., K. Strebel, M. D. Hoggan, M. A. Martin, and J. M. Orenstein. 1990. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64:621-629.
30. Kodama, T., D. P. W. Burns, H. W. Kestler, M. D. Daniel, and R. C. Desrosiers. 1990. Molecular changes associated with replication of simian immunodeficiency virus in human cells. J. Med. Primatol. 19:431-437.
31. Kodama, T., D. P. Wooley, Y. M. Naidu, H. W. Kestler, M. D. Daniel, Y. Li, and R. C. Desrosiers. 1989. Significance of premature stop codons in env of simian immunodeficiency virus. J Virol. 63:4709-4714.
32. Kong, L. L., S. Lee, J. C. Kappes, J. S. Parkin, D. Decker, J. A. Hoxie, B. H. Hahn, and G. M. Shaw. 1988. West African HIV-2-related human retrovirus with attenuated cytopathicity. Science 240:1525-1529.
33. Kumar, P., H. Hui, J. C. Kappes, B. S. Haggarty, J. A. Hoxie, S. K. Arya, G. M. Shaw, and B. H. Hahn. 1990. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J. Virol. 64:890-901.
34. LaBranche, C. C., M. M. Sauter, B. S. Haggarty, P. J. Vance, J. Romano, T. K. Hart, P. J. Bugelski, M. Marsh, and J. A. Hoxie. 1995 A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J. Virol 69:5217-5227.
35. Lodge, R., H. Gottlinger, D. Gabuzda, E. A. Cohen, and L. Guy. 1994. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68:4857-4861.
36. Mammano, F., E. Kondo, J. Sodroski, A. Bukovsky, and H. G. Gottlinger. 1995. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol 69:3824-3830.
37. Marlink, R., P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C.-C. Hsieh, M. Cire Dia, E.-H. Gueye, J. Hellinger, A. Gueye-Ndiaye, J.-L. Sankale, I. Ndoye, S. Mboup, and M. Essex. 1994 Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265: 1587-1590.
38. Miller, M. A., M. W. Cloyd, J. Liebmann, C. R. Rinaldo, K. R. Islam, S. Z. Wang, T. A. Mietzner, and R. C. Montelaro. 1993 Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196:89-100
39. Miller, M. A., R. F. Garry, J. M. Jaynes, and R. C. Montelaro. 1991 A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res. Hum. Retroviruses 7:511-519.
40. Miller, M. A., T. A. Mietzner, M. W. Cloyd, W. G. Robey, and R. C. Montelaro. 1993. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res. Hum. Retroviruses 9:1057-1066.
41. Mulligan, M. J., P. Kumar, H. Hui, R. J. Owens, G. D. Ritter, B. H. Hahn, and R. W. Compans. 1990. The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation. AIDS Res. Hum. Retroviruses 6:707-720.
42. Mulligan, M. J., G. D. Ritter, Jr., M. A. Chaikin, G. V. Yamshchikov, P. Kumar, B. H. Hahn, R. W. Sweet, and R. W. Compans. 1992. Human immunodeficiency virus type 2 envelope glycoprotem: differential CD4 interactions of soluble gp120 versus the assembled envelope complex. Virology 187:233-241.
43. Mulligan, M. J., G. V. Yamshchikov, G. D. Ritter, Jr., F. Gao, M. J. Jin, C. D. Nail, C. P. Spies, B. H. Hahn, and R. W. Compans. 1992. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:3971-3975
44. Myers, G., B. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis. 1993. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics, Los Alamos, N.Mex.
45. Owens, R. J., and R. W. Compans, 1989. Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J. Virol. 63:978-982.
46. Owens, R. J., J. W. Dubay, E. Hunter, and R. W. Compans. 1991. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl. Acad. Sci. 88:3987-3991.
47. Parent, L. J., R. P. Bennett, R. C. Craven, T. D. Nelle, N. K. Krishna, J. B. Bowzard, C. B. Wilson, B. S. Puffer, R. C. Montelaro, and J. W. Wills. 1995. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69:5455-5460.
48. Ramsey, C. A., and A. T. Panganiban. 1993. Human immunodeficiency virus type 1 Vpu has a CD4- and an envelope glycoprotein-independent function. J. Virol. 67:4190-4194.
49. Regier, D. A., and R. C. Desrosiers. 1990. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 6:1221-1231.
50. Ritter, G. D., M. J. Mulligan, S. L. Lydy, and R. W. Compans. 1993. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain Virology 197:255-264.
51. Salzwedel, K., P. B. Johnston, S. J. Roberts, J. W. Dubay, and E. Hunter. 1993 Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 67: 5279-5288.
52. Schubert, U., P. Henklein, S. Bour, T. Federau, M. Oblatt-Montal, M. Montai, and K. Strebel. 1995. The HIV-1 Vpu has ion channel forming activity, abstr. 45. p. 63. Presented at the 2nd National Conference: Human Retroviruses and Related Infections, Washington, D.C., January 1995.
53. Schubert, U., and K. Strebel. 1994 Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol 68:2260-2271.
54. Shimizu, H., F. Hasebe, H. Tsuchie, S. Morikawa, H. Ushijima, and T. Kitamura. 1992. Analysis of a human immunodeficiency virus type 1 isolate carrying a truncated transmembrane glycoprotein. Virology 189:534-546.
55. Spies, C. P., and R. W. Compans. 1994. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology 203:8-19.
56. Spies, C. P., G. D. Ritter, M. J. Mulligan, and R. W. Compans. 1994. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J. Virol. 68:585-591.
57. Srinivas, S. K., R. V. Srinivas, G. M. Anantharamaiah, J. P. Segrest, and R. W. Compans. 1992. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol. Chem. 267:7121-7127.
58. Strebel, K., T. Klimkait, and M. A. Martin. 1988. A novel gene of HIV-1, vpu. and its 16-kilodalton product Science 241:1221-1223.
59. Suomalainen, M., P. Liljestrom, and H. Garoff. 1992. Spike protein-nucleocapsid interactions drive the budding of alphaviruses J. Virol. 66:4737-4747.
60. Terwilliger, E. F., E. A. Cohen, Y. Lu, J. G. Sodroski, and W. A. Haseltine. 1989. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl Acad Sci. USA 86:5163-5167.
61. Travers, K., S. Mboup, R. Marlink, A. Gueye-Ndiaye, T. Siby, I. Thior, I. Traore, A. Dieng-Sarr, J.-L. Sankale, C. Mullins, I. Ndoye, C.-C. Hsieh, M. Essex, and P. Kanki. 1995. Natural protection against HIV-1 infection provided by HIV-2. Science 268:1612-5615.
62. Venable, R. M., R. W. Pastor, B. R. Brooks, and F. W. Carson. 1989. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res. Hum Retroviruses 5:7-22.
63. Wang, C.-T., Y. Zhang, J. McDermott, and E. Barklis. 1993. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67:7067-7076.
64. Wilk, T., T. Pfeiffer, and V. Bosch. 1992 Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189:167-177.
65. Yu, X., X. Yuan, Z. Matsuda, T.-H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions J. Virol. 66:4966-4971.
66. Yu, X., X. Yuan, M. F. McLane, T. Lee, and M. Essex. 1993. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67:213-221.
67. Zingler, K., and D. R. Littman. 1993. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity J Virol. 67: 2824-2831.